首页> 美国卫生研究院文献>Oxford Open >1983. Oral Therapy with Rifampin Associated with Minocycline or Moxifloxacin in Vertebral Osteomyelitis due to Gram-Positive Micro-organisms: A Retrospective Study of 64 Cases
【2h】

1983. Oral Therapy with Rifampin Associated with Minocycline or Moxifloxacin in Vertebral Osteomyelitis due to Gram-Positive Micro-organisms: A Retrospective Study of 64 Cases

机译:1983年。利福平联合米诺环素或莫西沙星口服治疗因革兰氏阳性微生物引起的椎体骨髓炎:64例回顾性研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

BackgroundIDSA guidelines about vertebral osteomyelitis (VO) recommend parenteral antimicrobial therapy (PAT) as the standard treatment for Gram-positive pathogens (GPP). In this setting, a switch to oral antimicrobial therapy (OAT) with excellent bioavailability could be considered. However, among fluoroquinolones, moxifloxacine is not recommended in staphylococcal VO, and among tetracycline, only doxycycline should be considered with rifampin, for brucelar VO. The aim of our study was to review the efficacy and safety of OAT with rifampin associated with moxifloxacin (Rif-Mox) or minocycline (Rif-Mino) in the treatment of VO due to GPP.
机译:BackgroundIDSA关于椎骨骨髓炎(VO)的指南建议将肠胃外抗菌治疗(PAT)作为革兰氏阳性病原体(GPP)的标准治疗方法。在这种情况下,可以考虑使用具有良好生物利用度的口服抗菌疗法(OAT)。然而,在氟喹诺酮类药物中,不建议在葡萄球菌VO中使用莫西沙星,而在四环素中,对于利福平VO,仅应将强力霉素与利福平一起使用。我们研究的目的是回顾与利福平联合莫西沙星(Rif-Mox)或米诺环素(Rif-Mino)联合使用的利福平对OAT的疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号